Search results for: COVID-19 Research
Filter search results
Would Waiving COVID-19 Vaccines Patents Save Lives?
18 May 2021
…https://www.economist.com/leaders/2021/05/15/ten-million-reasons-to-vaccinate-the-world[Accessed 17 May 2021]. KFF, 2021. Global COVID-19 Vaccine Access: A Snapshot of Inequality. KFF. Available at: https://www.kff.org/policy-watch/global-covid-19-vaccine-access-snapshot-of-inequality/ [Accessed 17 May 2021]. Euronews, 2021. EU nations divided over lifting COVID-19…
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…COVID-19 patients Amongst COVID-19 patients, existing vaccines can decrease mortality by helping to prevent those patients contracting other infections in addition to COVID-19. Pneumonia or seasonal influenza for example, due…
The broader economic benefits of COVID-19 vaccination
13 October 2025
…working and productive. Continued investment in comprehensive vaccination policies and COVID-19 vaccines is essential to reduce its ongoing and future burden. Extending COVID-19 vaccination eligibility to working-age adults could nearly…
Key Learnings From COVID-19: The Importance of Portfolio Management and How to Procure, Pay For, Distribute, and Use Vaccines During a Pandemic
21 April 2021
…on portfolio management, pricing, and procurement of COVID-19 vaccines (forthcoming as an OHE report) to organise the review. After the shock caused by the first wave of COVID-19, discovering vaccines…
The 2020 OHE Annual Lecture Explores the Question: How Should the World Pay for a COVID-19 Vaccine?
25 June 2020
…pay for a COVID-19 vaccine? Adrian Towse, Emeritus Director of OHE and Senior Research Fellow presents the challenges that we face in developing a COVID-19 vaccine, and suggests a mechanism…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…Pandemic. Available at: https://www.ohe.org/news/key-learnings-covid-19-importance-portfolio-management-and-how-procure-pay-distribute-and-use Steuten, L., Bell, E. and Neri, M., 2020. The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision. Available at: https://www.ohe.org/news/broader-value-existing-vaccines-fight-against-covid-19-beware-tunnel-vision…
Infectious disease: another reason to try Veganuary for the NHS
30 January 2025
…2024. Papadaki and colleagues report the risk of both COVID-19 infection and COVID-19 hospitalisation, deriving evidence from a total of 649,315 participants across seven studies. Headline findings include plant-based diets…
How Should the World Pay for a COVID-19 Vaccine?
31 July 2020
…COVID-19. One ‘exit strategy’ from this health and economic crisis is the development of a safe and effective vaccine. A herculean effort to develop a COVID-19 vaccine began 6 months…
The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?
22 May 2020
…COVID-19 devolves into a bidding war among countries, this disease will kill many more people than it has to”. Mechanisms which provide incentives for continued private sector research and which…